Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis

Cancer Research

Volumn 57, Issue 5, 1997, Pages 963-969

  Relf, Michele ^a   Lejeune, Susan ^a   Scott, Prudence A E ^a   Fox, Stephen ^a   Smith, Kenneth ^a   Leek, Russell ^a   Moghaddam, Amir ^a   Whitehouse, Ruth ^a   Bicknell, Roy ^a   Harris, Adrian L ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; CANCER GROWTH FACTOR; ESTROGEN RECEPTOR; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; BREAST CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

BREAST NEOPLASMS; CARRIER PROTEINS; CYTOKINES; DISEASE-FREE SURVIVAL; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; LYMPHOKINES; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PREGNANCY PROTEINS; RNA, MESSENGER; THYMIDINE PHOSPHORYLASE; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031038068     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst,. 82: 4-6, 1990.
2. Denekamp, J. Inadequate vasculature in solid tumours: consequences for cancer research strategies. Br. J. Radiol., 24: 111-117, 1992.
3. Horak, E. R., Leek, R., Klenk, N., LeJeune, S., Smith, K., Stuart, N., Greenall, M., Stepniewska, K., and Harris, A. L. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet, 340: 1120-1124, 1992.
4. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. A., Moore, H., Meli, S., and Gasparini, G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma, J. Natl. Cancer Inst., 84: 1875-1887, 1992.
5. Dickinson, A. J., Fox, S. B., Persad, R. A., Hollyer, J., Sibley, G. N. A., and Harris, A. L. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br. J. Urol., 74: 762-766, 1994.
6. Fox, S. B., Gatter, K. C. Bicknell, R., Going, J. J., Stanton, P., Cooke, T. G., and Harris, A. L. Relationship of endothelial-cell proliferation to tumor vascularity in human breast-cancer. Cancer Res., 53; 4161-4163, 1993.
7. Scott, P. A. E., and Harris A. L. Current approaches to targeting cancer using antiangiogenesis therapies. Cancer Treat. Rev., 20: 393-412, 1994.
8. Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B., and Leung, D. W. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing. Mol. Endocrinol., 5: 1806-1814, 1991.
9. Slavin, J. Fibroblast growth factors: at the heurt of angiogenesis. Cell Biol. Int., 19: 431-444, 1995.
10. Fang, W., Hartmann, N., Chow, D. T., Riegel, A. T., and Wellstein, A. Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer. J. Biol. Chem., 267: 25889-25897, 1992.
11. Riegel, A. T., and Wellstein, A. The potential role of the heparin-binding growth-factor pleiotrophin in breast-cancer. Breast Cancer Res. Treat., 31: 309-314, 1994.
12. Sunderkotter, C., Steinbrink, K., Goebeler, M., Bhardwaj, R., and Sorg, C. Macrophages and angiogenesis. J. Leukocyte Biol., 55: 410-422, 1994.
13. Ishikawa, K., Miyazono, U., Hellman, H., Drexler, C., Wernstedt, K., Hagiwara, K., Usuki, F., Takaku, K., Risau, W., and Heldin, C. H. Identification of the angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature (Lond.), 338: 557-562, 1989.
14. Sumizawa, T., Furukawa, T., Haraguchi, M., Yoshimura. A., Takeyasu, A., Ishizawa, M., Yamada, Y., and Akiyama, S. Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. J. Biochem. (Tokyo), 114: 9-14. 1993.
15. Moghaddam, A., Zhang, H. T., Fan, T. P., Hu, D. E., Lees, V. C., Turley, H., Fox, S. B., Gatter, K. C., Harris, A. L., and Bicknell, R. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc. Natl. Acad. Sci. USA, 92: 998-1002, 1995.
16. Sacks, P. M., Smith, K., Norman, A, P., Greenall. M., LeJeune, S., and Harris, A. L. Cathepsin D levels in primary breast cancers: relationship with epidermal growth factor receptor, oestrogen receptor and axillary node status. Eur. J. Cancer, 29A: 426-428, 1993.
17. Fox, S. B,. Leek, R. D., Weekes, M. P., Whitehouse, R. M., Gatter, K. C., and Harris, A. L. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density. Chalkley count and computer image analysis. J, Pathol., 777: 275-283, 1995.
18. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guonldium thiocyanate-phenol-chloroform extraction. Anal, Biochem., 162: 156-159, 1987.
19. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. Current Protocols in Molecular Biology, pp. 4.7.1-4.7.6. John Wiley and Sons, 1994.
20. McCarthy, S. A., and Bicknell, R. Responses of pertussis toxin treated microvascular endothelial cells to transforming growth factor b, No evidence for G-protein involvement. J. Biol. Chem, 267; 21617-21622, 1992.
21. Nicholson, S., Sainsbury, J. R., Needham, G. K., Chambers, P., Farndon, J. R., and Harris, A. L. Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance, Int. J. Cancer, 42: 36-41, 1988.
22. Fox, S. B., Westwood, M., Moghaddam, A., Comley, M., Turley, H., Whitehouse, R. M., Bicknell, R., Gaiter, K. C., and Harris, A. L. The angiogenic factor plateletderived endothelial cell growth factor thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br. J. Cancer, 73: 275-280, 1996.
23. Connolly, D. T. Vascular permeability factor: a unique regulator of blood vessel function. J. Cell. Biochem., 47: 219-223, 1991.
24. Houck, K. A., Leung, D. W., Rowland, A. M., Winer. J., and Ferrara, N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem., 267: 26031-26037, 1992.
25. Berkman, R. A., Merrill, M. J., Reinhold, W. C., Monacci, W. T., Saxena, A., Clark, W. C., Robertson, J. T., AH, I. U., and Oldfield, E. H. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J. Clin. Invest., 91: 153-159, 1993.
26. Toi, M., Hoshina, S., Takayanagi, T., and Tominaga, T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn. J. Cancer Res., 85: 1045-1049, 1994.
27. Pepper, M. S., Ferrara, N., Orci, L,. and Montesano, R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun., 189: 824-831, 1992.
28. Janot, F. N. A., Morrison, R. S., Liu, T. J.,Taylor, D. L., and dayman, G. L. Expression of basic fibroblasi growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologie differentiation. Int. J. Cancer, 64: 117-123, 1995.
29. van der Laan, B. F,. Freeman, J. L., and Asa, S. L. Expression of growth factors and growth factor receptors in normal and tumorous human thyroid tissues. Thyroid, 5: 67-73, 1995.
30. Vlodavsky, I., Fuks, Z., Ishai-Michaeli, R., Bashkin, P., Levi, E,. Korner, G., Bar-Shavit, R., and Klagsrun, M. Extracellular matrix-resident basic fibroblast growth factor: implication for the control of angiogenesis. J. Cell. Biochem., 45: 167-179, 1991.
31. Brunner, N., Pyke, C., Hansen, C. H., Romer, J., Grondahl, H. J., and Dano, K. Urokinase plasminogen activator (uPA) and its type I inhibitor (PAI-1): regulators of proteolysis during cancer invasion and prognostic parameters in breast cancer. Cancer Treat. Res., 71: 299-309, 1994.
32. Luqmani, Y. A., Graham, M., and Coombes, R. C. Expression of basic fibroblast growth factor, FGFR1 and FGFR2, in normal and malignant human breast, and comparison with other normal tissues. Br. J. Cancer, 66: 273-280, 1992.
33. Maglione, D., Guerriero, V., Viglietto, G., Ferraro, M. G., Aprelikova, O., Alitalo, K., Del Vecchio, S., Lei, K-J., Yang Chou, J., and Persico, M. G. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (P1GF). are transcribed from a single gene of chromosome 14. Oncogene, 8: 925-931. 1993.
34. Phillips, G. D., Whitehead, R. A., Stone, A. M., Ruebel, M, W., Goodkin, M. L., and Knighton, D. R. Transforming growth factor beta (TGF-β) stimulation of angiogenesis: an electron microscopic study. J. Suhmicrosc. Cytol. Pathol., 25: 149-155, 1993.
35. Gruber, B. L., Marchese. M. J., and Kew, R. Angiogenic factors stimulate mast-cell migration. Blood. 86: 2488-2493, 1995.
36. Ueki, N., Nakazato, M., Ohkawa, T., Ikeda, T., Amuro, Y., Hada, T., and Higashino, K. Excessive production of transforming growth-factor beta 1 can play an important role in the development of tumorigencsis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth. Biochim, Biophys, Acta. 1137: 189-196, 1992.
37. Folkman, J., and Hanahan, D. Switch to the angiogenic phenotypc during lumorigenesis, In: C. C. Harris (ed.), Multistage Carcinogenesis, pp. 339-347. Tokyo: Japan Scientific Societies Press, 1992.
38. Millauer, B., Shawver, L. K., Plate, K. H., Risau, W., and Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant, Nature (Lond.), 367: 576-579, 1994.
39. Zugmaier, G., Lippman, M. E. and Wellstein, A. Inhibition by pentosan polysulphate (PPS) of heparin-binding growth factors released from tumour cells and blockage by PS of tumour growth in animals. J. Natl. Cancer Inst., 84: 1716-1724, 1992.
40. Pesenti, E., Sola, F., Mongelli, N., Grandi, M., and Spreafico, F. Suramin prevents neovasculurisation and tumour growth through blocking of basic fibroblast growth factor activity. Br. J. Cancer, 66: 367-372, 1992.
41. Takano, S,. Gately, S., Neville, M. E., Herblin, W. F., Gross, J. L., Engelhard, H., Perricone, M., Eidsvoog, K., and Brem, S. Suramin: an anticancer and angiosuppressive agent, inhibits cndotheliul cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator. Cancer Res., 54: 2654-2660, 1994.
42. Bruddock, P., Hu, D-E., Fan, T-P., Stratford, I., Harris, A., and Bicknell, R. A structure-activity analysis of antagonism of the growth factor and angiogonic activity of basic fibroblust growth factor by suramin and related polyanions. Br. J. Cancer, 69: 890-898, 1994.
43. Ingber, D., Fujita, D., Kishimoto, S., Sudo, K., Kanumaru, T., Brem, H., and Folkman, J. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. 348: 555-557, 1990.
44. Kamei, S., Okada, H., Inoue, Y., Yoshioka, T., Ogawa, Y., and Toguchi, H. Antitumour effects of angiogenesis inhibitor TNP-4709 in rabbits bearing VX-2 carcinoma by arterial administration of microspheres and oil solution. J. Pharmacol, Exp. Ther., 264: 469-474, 1993.
45. Takamiya, Y., Friedlander, R. M., Brem. H., Malick, A., and Martuza, R. L. Inhibition of angiogenesis and growth of human nerve-sheath tumors by AGM 1470. J. Neurosurg., 78: 470-476, 1993.
46. Biro, S., Siegall, C. Fu, Y-M., Speir, E., Pustan, I., and Epstein, S. E. In vitro effects of a recombinant toxin targeted to the fibroblast growth factor receptor on rat vascular smooth muscle and endothelial cells. Circ. Res., 71: 640-645, 1992.